MitoTALEN reduces mutant mtDNA load and restores tRNAAla levels in a mouse model of heteroplasmic mtDNA mutation

Overview of attention for article published in Nature Medicine, September 2018

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (98th percentile)
Good Attention Score compared to outputs of the same age and source (77th percentile)

Mentioned by

news: 10 news outlets
blogs: 2 blogs
twitter: 128 X users
patent: 7 patents

facebook: 2 Facebook pages
googleplus: 7 Google+ users
reddit: 3 Redditors

Readers on

mendeley: 253 Mendeley

So far, Altmetric has seen 141 X posts from 128 X users, with an upper bound of 1,719,407 followers.

RT @VamsiMootha: Gene therapy for #mitochondria disease: two papers showcasing the the power of mitoTALEN and mitoZFN technology to target…

RT @AndyBiotech: Here comes genome editing in mitochondria, which appear to be off-limits to #CRISPR https://t.co/z6cqYlieoI $SGMO mtZFN…

RT @MPIAGE: Milestone: gene therapy for mitochondrial diseases. Two exciting papers demonstrate how mutated mitochondrial DNA can be reduce…

RT @Biotech2050: $SGMO https://t.co/zoVGfDR8MY

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 137 additional X posts.